[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=AKRO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=AKRO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

12.58

Margin Of Safety %

Put/Call OI Ratio

0.21

EPS Next Q Diff

-0.11

EPS Last/This Y

0.03

EPS This/Next Y

-0.52

Price

43.45

Target Price

73.5

Analyst Recom

Performance Q

-18.86

Relative Volume

1.11

Beta

-0.29

Ticker: AKRO

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-08-15	AKRO	49.39	0.36	0.74	40640
2025-08-18	AKRO	48.6	0.22	0.03	22475
2025-08-19	AKRO	47.6	0.20	0.07	25099
2025-08-20	AKRO	47.94	0.19	0.04	26344
2025-08-21	AKRO	48.26	0.19	0.10	26587
2025-08-22	AKRO	49.22	0.19	0.04	26613
2025-08-25	AKRO	47.02	0.19	0.02	26649
2025-08-26	AKRO	48.07	0.19	0.13	26830
2025-08-27	AKRO	48.23	0.20	0.26	27049
2025-08-28	AKRO	46.92	0.20	1.00	27467
2025-08-29	AKRO	46.71	0.21	0.01	27697
2025-09-02	AKRO	45.44	0.20	0.47	28192
2025-09-03	AKRO	45.65	0.21	0.04	29093
2025-09-04	AKRO	44.01	0.21	1.56	29170
2025-09-05	AKRO	44.72	0.21	0.01	29248
2025-09-08	AKRO	44.6	0.21	0.04	29477
2025-09-09	AKRO	44.65	0.21	0.50	29588
2025-09-10	AKRO	43.26	0.21	1.15	29598
2025-09-11	AKRO	44.92	0.21	0.05	29546
2025-09-12	AKRO	43.49	0.21	0.07	29647
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-08-15	AKRO	49.38	12.5	-58.0	-3.72
2025-08-18	AKRO	48.58	12.5	-57.1	-3.72
2025-08-19	AKRO	47.60	12.5	-55.3	-3.72
2025-08-20	AKRO	47.95	12.5	-67.0	-3.72
2025-08-21	AKRO	48.26	12.5	-66.6	-3.72
2025-08-22	AKRO	49.18	12.5	-71.6	-3.72
2025-08-25	AKRO	47.00	12.5	-44.9	-3.72
2025-08-26	AKRO	48.12	12.5	-73.6	-3.72
2025-08-28	AKRO	46.94	12.5	-53.0	-3.69
2025-08-29	AKRO	46.70	12.5	-61.8	-3.69
2025-09-02	AKRO	45.42	12.5	-52.0	-3.69
2025-09-03	AKRO	45.63	12.5	-133.5	-3.69
2025-09-04	AKRO	44.01	12.5	-113.4	-3.69
2025-09-05	AKRO	44.72	12.5	-139.3	-3.66
2025-09-08	AKRO	44.57	12.7	-129.7	-3.66
2025-09-09	AKRO	44.64	11.2	-132.2	-3.72
2025-09-10	AKRO	43.24	11.2	-115.6	-3.72
2025-09-11	AKRO	44.93	11.2	-151.4	-3.72
2025-09-12	AKRO	43.45	11.2	-114.4	-3.72
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-08-15	AKRO	-3.25	20.76	11.26
2025-08-18	AKRO	-3.25	16.54	11.49
2025-08-19	AKRO	-2.75	16.54	11.49
2025-08-20	AKRO	-2.75	16.54	11.49
2025-08-21	AKRO	-2.75	16.54	11.49
2025-08-22	AKRO	-2.64	16.54	11.49
2025-08-25	AKRO	-2.64	9.56	11.49
2025-08-26	AKRO	-2.64	9.56	11.49
2025-08-27	AKRO	-2.64	9.56	13.05
2025-08-28	AKRO	-2.64	9.56	13.05
2025-08-29	AKRO	-2.64	9.56	13.05
2025-09-02	AKRO	-2.64	9.45	13.05
2025-09-03	AKRO	-2.64	9.45	13.05
2025-09-04	AKRO	-2.64	9.45	13.05
2025-09-05	AKRO	-2.77	9.45	13.05
2025-09-08	AKRO	-2.12	9.54	13.05
2025-09-09	AKRO	-2.12	9.54	13.05
2025-09-10	AKRO	-2.12	9.54	13.05
2025-09-11	AKRO	-2.25	9.54	12.58
2025-09-12	AKRO	-2.25	9.54	12.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=AKRO 589 360 ]

Last Quarter Act. EPS

-0.86

Avg. EPS Est. Current Quarter

-0.93

Avg. EPS Est. Next Quarter

-0.97

Insider Transactions

-2.25

Institutional Transactions

9.54

Beta

-0.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.6

Max Drawdown 5-Year %

-80

Target Price

73.5

P/E

Forward P/E

PEG

P/S

P/B

3.39

P/Free Cash Flow

EPS

-3.8

Average EPS Est. Cur. Y

-3.72

EPS Next Y. (Est.)

-4.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.11

Return on Equity vs Sector %

-52.6

Return on Equity vs Industry %

-39.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.12

EBIT Estimation

-114.4

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=AKRO 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=AKRO 589 450 ]

Akero Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 67

Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

stock quote shares AKRO – Akero Therapeutics Inc Stock Price stock today

news today AKRO – Akero Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch AKRO – Akero Therapeutics Inc yahoo finance google finance

stock history AKRO – Akero Therapeutics Inc invest stock market

stock prices AKRO premarket after hours

ticker AKRO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AKRO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y